ArticleERJ open research2023
Clinical response to benralizumab can be predicted by combining clinical outcomes at 3 months with baseline characteristics.
Johannes A Kroes et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this paperpooled itcites it